Anthrax: A narrative review.
Creators
- 1. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India.
- 2. Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences & Research, Durgapur, 713212, West Bengal, India.
- 3. Department of Microbiology, Ramakrishna Mission Vivekananda Centenary College, Rahara, Kolkata, 700118, West Bengal, India.
- 4. UNESCO Regional Centre for Biotechnology, Department of Biotechnology, Government of India, NCR Biotech Science Cluster, Faridabad, 121001, Haryana, India.
- 5. Department of Pharmaceutics, Yenepoya Pharmacy College & Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, 575018, India.
- 6. Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, India.
- 7. Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
- 8. Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, Uttarakhand, India.
- 9. Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, 47500, Selangor Darul Ehsan Malaysia.
- 10. Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Malaysia, Jalan Lagoon Selatan, Bandar Sunway, 47500, Selangor Darul Ehsan, Malaysia.
- 11. Monash University
Description
Bacillus anthracis is a zoonotic bacterium, majorly responsible for causing human anthrax and the possibility of the outbreak spreading globally. Herbivorous animals serve as the inherent reservoir for the disease, whereas all endothermic species are vulnerable. Humans contract the disease inadvertently by contact with diseased animals or animal products or through the consumption or handling of infected flesh. There is no such reported data indicating the transmission of anthrax from human to human, which further does not guarantee the bacterium's mutations and new transmission route. Nevertheless, it can lead to various infections, including endophthalmitis, bacteremia, cutaneous infection, central nervous system infection, and pneumonia. Therefore, it is crucial to examine the present epidemiological situation of human anthrax in densely populated nations, including the altered symptoms, indications in people, and the method of transmission. This article highlights the current diagnostic methods for human anthrax, further examines the available therapy options and future perspectives in treatment protocol. This narrative review resulted from a simple search strategy on "PubMed", "ScienceDirect", "ClinicalTrials.gov" and web reports using "AND" as Boolean operator with search keywords, i.e., "Anthrax" AND "Infection", "Anthrax" AND "Pandemic", "Anthrax" AND "Infectious disease", "Anthrax" AND "Vaccine", "Anthrax" AND "Diagnosis" shows minimal narrative literature in between 2024 and 2005. Furthermore, this narrative review highlights the potential approaches for detecting anthrax infection, establishing suitable protocols for prevention, and focusing on the current epidemiology and available therapeutics, vaccine and its future developmental strategies for the prevention of infectious disorder.
Open Access
Licence Attribution (CC BY)
Publisher Website
Access full text
Publication Details
Journal article
Journal:
New microbes and new infections
Publisher:
Elsevier BV
ISSN:
20522975
Volume:
62
Pages:
101501-101501
Persistent Identifiers
References
Baillie . The development of new vaccines against Bacillus anthracis, J Appl Mic...
Read more
Yu . Combinations of various CpG motifs cloned into plasmid backbone modulate an...
Read more
Liu . Anthrax lethal and edema toxins in anthrax pathogenesis, Trends Microbiol....
Read more
Guichard . New insights into the biological effects of anthrax toxins: linking c...
Read more
McGovern . In situ detection of Bacillus anthracis spores using fully submersibl...
Read more
Showing first 5 of 94 references.